Drugmaker Pfizer has updated the U.S. labels for the smoking-cessation medication Chantix to more prominently display warnings about erratic behavior in some users. The new labels warn that Chantix users should be monitored for 'serious psychiatric symptoms, including changes in behavior, agitation, depressed mood, suicidal ideation and suicidal behavior.' Since the drug's launch in 2006, both Pfizer and the U.S. Food and Drug Administration have received reports of abnormal behavior in Chantix...
Read moreIf you do a search of the questions we receive on MyDepressionConnection you will find that the number one inquiry is about the topic of... Read more »
Happy Thanksgiving! Next week, President Obama will issue a pardon to another fortunate turkey while most of us partake in the yearly... Read more »
Teens face challenges and pressures and expectations and their own personal development issues. So it's not surprising that the teen... Read more »
It has long been stated that women in menopause do not experience more depression or mood disorders than at other times in life. However,... Read more »
Best Preventive Medicine without a prescription. The evidence is overwhelming: a balanced diet combined with moderate exercise is one of... Read more »
Results from a new clinical trial show that the new anticoagulant Xarelto lowers the risk of heart attack, stroke, and death people who have had a... Read more »
Three research teams are reporting positive results for a new blood thinner, saying the drug performed well in hip and knee replacement patients in... Read more »
Anti-social behavior among young elementary school girls and increased anxiety in either boys or girls that age tend to predict whether they develop... Read more »
It’s long been known that there is a link between chronic pain and depression, but a new study suggests there may be a connection between the drugs... Read more »